Sources
Loading...
Additional media
Loading...
Arbutus and Genevant have gained an advantage in their patent infringement lawsuit against Moderna, as a judge ruled in their favor in the claim construction order. Moderna's shares fell following the court decision.
Arbutus, Genevant gain an edge in COVID patent scrap with Moderna https://t.co/Y9HpI7y6XP
$ABUS IF this company weren't a complete scientific and clinical train wreck, I'd have held stock through patent decision. Looking promising though. https://t.co/adWroO3YL9
$ABUS announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against $MRNA https://t.co/UoLdyvwgra